that it has agreed to sell its global pharmaceutical division Solvay Pharmaceuticals Global to Abbott Laboratories, Inc. of Abbott Park, IL for approximately $6.6 billion cash. Solvay Pharmaceuticals Global reports annual revenues of approximately $3.9 billion, of which approximately $1.2 billion is generated by Solvay Pharmaceuticals US, and employs 9,600 people. This acquisition by Abbott will return the US division of Solvay Pharmaceuticals, plus the European division, to American management and an American board of directors. Theodore H. Rowell Graduate Fellowship at the University of Minnesota School of Pharmacy After Ted Sr's death, the Rowell family set up the Theodore H. Rowell Graduate Fellowship at the University of Minnesota for graduate students in the College of Pharmacy. Grants range from $3,000 to $6,000 with preference to Minnesota residents who are US citizens. Rowell Laboratories, Inc. today Rowell Laboratories, Inc. was re-incorporated in 2008 as a Florida corporation and manufactures natural and homeopathic health care products under the NatureCare brand. Rowell firsts 1932 Burbot Liver Oil 1937 Rowell Burbot Liver Oil accepted by American Medical Association 1938 First injectable vitamin A 1944 First dry fill multiple vitamin capsule 1947 Vio-Bec the first ultrahigh-potency therapeutic B complex 1949 First PAS in dosage forms 1950 Vio-Dex, first anti-obesity product with multi-vitamin/amphetamine 1957 C-Ron, first ferrous fumarate and vitamin C product 1958 Residerm, first ion exchange resin for treatment of Rhus dermatosis (poison ivy) 1961 Vio-Dexose, unique anti-obesity therapy 1966 First to develop a hydrocortisone retention enema for Ulcerative Colitis 1967 First to file an NDA for Lithium Carbonite, for manic patients. The FDA held up the Rowell NDA to allow 2 large competitors to catch up, thus taking a large piece of Rowell's market share and giving it to the other 2 companies. 1967 First FDA approval 2x per day Lithium dosage 1973 NDA 83-009 for ORASONE Tablets, 1 mg., 5 mg., 10 mg., and 20 mg. 1976 Rowell products onboard NASA's Skylab 1979-1983 numerous patents for controlled release of solid dose tablets to ensure consistent rate of drug release as tablet reduces in size 1980 Advancement in bulk laxative sugar free psyllium compositions for ease of mixing 1981 Chenix, first US approved drug for dissolution of gallstones 1988 Rowasa, first 5-ASA enema treatment for Ulcerative colitis Patents held US Patent 4539198 – Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range US Patent 4264573 – Pharmaceutical formulation